BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 873621)

  • 1. Killer cell (K) activity in human normal lymph node, regional tumour lymph node and inflammatory lymph node.
    Eremin O; Ashby J; Franks D
    Int Arch Allergy Appl Immunol; 1977; 54(3):210-20. PubMed ID: 873621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T and B lymphocyte populations in human normal lymph node, regional tumour lymph node and inflammatory lymph node.
    Eremin O; Plumb D; Coombs RR
    Int Arch Allergy Appl Immunol; 1976; 52(1-4):277-90. PubMed ID: 1087920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human lymph node lymphocytes fail to effect lysis of antibody-coated target cells.
    O'Toole C; Saxon A; Bohrer R
    Clin Exp Immunol; 1977 Jan; 27(1):165-71. PubMed ID: 300304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease.
    Eremin O; Ashby J; Stephens JP
    Int J Cancer; 1978 Jan; 21(1):35-41. PubMed ID: 342425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological characterization of mononuclear cells in peripheral blood and regional lymph nodes of breast cancer patients.
    Heidenreich W; Jagla K; Schüssler J; Börner P; Dehnhard F; Kalden JR; Leibold W; Peter HH; Deicher H
    Cancer; 1979 Apr; 43(4):1308-13. PubMed ID: 376089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human regional tumour lymph nodes: alterations of micro-architecture and lymphocyte subpopulations.
    Eremin O; Roberts P; Plumb D; Stephens JP
    Br J Cancer; 1980 Jan; 41(1):62-72. PubMed ID: 7362780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.
    Vose BM; Vánky F; Klein E
    Int J Cancer; 1977 Dec; 20(6):895-902. PubMed ID: 591128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of axillary lymph node cells in patients with breast cancer.
    Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
    J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
    Morton BA; Ramey WG; Paderon H; Miller RE
    Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface immunoglobulin positive lymphocytes in human breast cancer tissue and homolateral axillary lymph nodes.
    Richters A; Kaspersky CL
    Cancer; 1975 Jan; 35(1):129-33. PubMed ID: 1089036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy.
    Flannery GR; Chalmers PJ; Rolland JM; Nairn RC
    Br J Cancer; 1973 Aug; 28(2):118-22. PubMed ID: 4542343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node anti-tumour effector cell mechanisms in colorectal carcinoma.
    Werkmeister JA; Pihl E; Flannery GR
    Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):115-24. PubMed ID: 7259635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the regional lymph node in breast cancer: a comparison between nodal and systemic reactivity.
    Reiss CK; Volenec FJ; Humphrey M; Singla O; Humphrey LJ
    J Surg Oncol; 1983 Apr; 22(4):249-53. PubMed ID: 6834845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph nodes and human tumors (review).
    Lores B; García-Estevez JM; Arias C
    Int J Mol Med; 1998 Apr; 1(4):729-33. PubMed ID: 9852289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic competence of regional lymph nodes in patients with breast cancer.
    Ellis RJ; Wernick G; Zabriskie JB; Goldman LI
    Cancer; 1975 Mar; 35(3):655-9. PubMed ID: 1111934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native and inducible levels of natural cytotoxicity in lymph nodes draining mammary carcinoma.
    Kimber I; Moore M; Howell A; Wilkinson MJ
    Cancer Immunol Immunother; 1983; 15(1):32-8. PubMed ID: 6553505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary lymph nodes and serum immunoglobulins in breast cancer.
    Lee YT; Richters A
    J Am Med Womens Assoc (1972); 1977 Dec; 32(12):455-6, 461-6. PubMed ID: 201690
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
    Saxon A; Portis J
    Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cellular cytotoxicity in the rat, rabbit, and guinea pig: relationship of killer (K) cell activity with the presence of Fc+ C3- and Fc+ C3+ lymphocytes.
    Eremin O; Wilson AB; Coombs RR; Plumb D; Ashby J
    Cell Immunol; 1979 Oct; 47(2):332-46. PubMed ID: 487451
    [No Abstract]   [Full Text] [Related]  

  • 20. Flow cytometric analysis of tumour-draining lymph nodes in breast cancer patients.
    Whitford P; Alam SM; George WD; Campbell AM
    Eur J Cancer; 1992; 28(2-3):350-6. PubMed ID: 1591050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.